Inventor · disambiguated record
Francis Hubler
Also filed as: HUBLER FRANCIS
19 granted patents·7 pending applications·56 citations·filing 2002–2022
91Inventor score
Files withIDORSIA PHARMACEUTICALS LTD8HILPERT KURT6ACTELION PHARMACEUTICALS LTD5CAROFF EVA4ABELE STEFAN1
Top patents by PatentIndex Score
26 records- 0188US8058263B2Substituted 2-phenyl-pyridine derivativesCAROFF EVA·Filed 2009·Granted Nov 15, 2011·9 cites·19 claims
- 0284US8518912B2Phosphonic acid derivates and their use as P2Y12 receptor antagonistsCAROFF EVA·Filed 2008·Granted Aug 27, 2013·9 cites·39 claims
- 0384US8048881B2Pyrimidine derivatives and their use as P2Y12 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·9 cites·16 claims
- 0482US8664203B2Thiazole derivatives and their use as P2Y12 receptor antagonistsCAROFF EVA·Filed 2010·Granted Mar 4, 2014·4 cites·14 claims
- 0582US8288385B26-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidinesCAROFF EVA·Filed 2010·Granted Oct 16, 2012·7 cites·16 claims
- 0682US8202885B2Bridged six-membered ring compoundsHILPERT KURT·Filed 2008·Granted Jun 19, 2012·7 cites·27 claims
- 0780US9221832B2Heterocyclic amide derivatives as P2X7 receptor antagonistsHILPERT KURT·Filed 2012·Granted Dec 29, 2015·6 cites·14 claims
- 0870US8492555B2Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl esterABELE STEFAN·Filed 2009·Granted Jul 23, 2013·2 cites·13 claims
- 0968US2023192708A12,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1062US6995139B2Cyclic undecapeptide pro-drugs and uses thereofDEBIOPHARM SA·Filed 2002·Granted Feb 7, 2006·3 cites·15 claims
- 1161US2025042881A1Ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1261US2025011313A1Ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1352US8314253B2Bridged tetrahydronaphthalene derivativesHILPERT KURT·Filed 2009·Granted Nov 20, 2012·0 cites·14 claims
- 1451US11608341B2Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Mar 21, 2023·0 cites·22 claims
- 1551US8436205B2Tetrahydronaphthalene compoundsHILPERT KURT·Filed 2009·Granted May 7, 2013·0 cites·11 claims
- 1651US2011039905A1Benzimidazole derivatives as calcium channel blockersHUBLER FRANCIS·Filed 2009·Application pending·0 cites
- 1751US2023174514A1Azetidin-3-ylmethanol derivatives as ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1847US11685729B2C5a receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jun 27, 2023·0 cites·18 claims
- 1946US9388198B2Heterocyclic amide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jul 12, 2016·0 cites·17 claims
- 2045US9388197B2Heterocyclic amide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jul 12, 2016·0 cites·19 claims
- 2145US2022265658A1Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compoundIDORSIA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 2244US9718774B2Indole carboxamide derivatives as P2X7 receptor antagonistACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Aug 1, 2017·0 cites·19 claims
- 2344US9556117B2Indole carboxamide derivatives as P2X7 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Jan 31, 2017·0 cites·14 claims
- 2443US11739070B2C5A receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Aug 29, 2023·0 cites·16 claims
- 2540US9409917B2Heterocyclic amide derivatives as P2X7 receptor antagonistsHILPERT KURT·Filed 2013·Granted Aug 9, 2016·0 cites·16 claims
- 2639US2014073651A1Benzamide derivatives as p2x7 receptor antagonistsHILPERT KURT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francis Hubler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →